NASDAQ:BCEL
Delisted

Atreca Stock News

etoro logo Buy BCEL
*Your capital is at risk
$0.0900
+0 (+0%)
At Close: Sep 13, 2024

Atreca (NASDAQ:BCEL) Trading 7.7% Higher

10:16am, Tuesday, 07'th Apr 2020
Shares of Atreca (NASDAQ:BCEL) traded up 7.7% on Monday . The company traded as high as $14.38 and last traded at $13.48, 307,075 shares traded hands during mid-day trading. An increase of 36% from th
SOUTH SAN FRANCISCO, Calif., April 06, 2020 -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique.
These three clinical-stage biotechs are all bargains after last month's marketwide downturn.
Greek authorities isolate Ritsona camp as 23 migrants test positive close to capital, Athens
GREECE and the European Union have been warned "there is not much time left" to stop an explosion of coronavirus cases erupting on its Aegean islands, as thousands of refugees continue to travel from
GREECE must act now if it is to stem the devastating refugee crisis that threatens to see its beautiful islands decimated with the deadly coronavirus.
NGOs warn lone children in particular have been effectively abandoned as Covid-19 forces support services to shut
'What I saw influenced me to work with people affected by conflicts and disasters so I left the Army and joined the humanitarian aid sector'
Canaccord Genuity analyst John Newman maintained a Buy rating on Atreca (BCEL) yesterday and set a price target of $23.00. The company's shares closed
Canaccord Genuity analyst John Newman maintained a Buy rating on Atreca ( BCEL – Research Report ) yesterday and set a price target of $23.00 . The company’s shares closed last Monday at $13.62. A
iMessage is one of Apple’s most used features, and Dan Moren thinks iOS 14 is a good time to give it a boost.
NEW YORK, March 12, 2020 -- Pomerantz LLP is investigating claims on behalf of investors of Atreca, Inc. (“Atreca” or the “Company”) (NASDAQ: BCEL).   Such investors are.
SOUTH SAN FRANCISCO, Calif., March 11, 2020 -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated.

These 14 Stocks Are Stupid Cheap

07:00pm, Sunday, 08'th Mar 2020
The coronavirus induced sell-off has created a number of attractive buying opportunities.
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE